Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2027 - Players Include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals and CureVac Among Others
March 08, 2022 07:13 ET
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Worldwide RNA Interference (RNAi) Drug Delivery" report has been added to ResearchAndMarkets.com's offering. The global RNA interference (RNAi) drug...
Global RNA Analysis / Transcriptomics Market Report 2021: Market to Reach $10.5 Billion by 2026 - Reagents / Consumables to Account for $5.9 Billion
January 19, 2022 05:53 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "RNA Analysis / Transcriptomics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global RNA...
Global RNA Interference Drug Delivery Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
October 28, 2021 05:58 ET
|
Research and Markets
Dublin, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Transfection Technologies Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
September 06, 2021 05:58 ET
|
Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Insights on the Gene Expression Analysis Global Market to 2026 - by Products & Services, Technology, Capacity, End-user and Region
July 15, 2021 08:23 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Notice of half year results
July 15, 2021 07:00 ET
|
Silence Therapeutics plc
Silence Therapeutics Notice of Half Year Results 15 July 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and...
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases
April 28, 2021 07:00 ET
|
Silence Therapeutics plc
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases 28 April 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq:...
Global RNA Interference Drug Delivery Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
December 21, 2020 06:53 ET
|
Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...